{"id":"https://openalex.org/W2065024741","doi":"https://doi.org/10.1158/1538-7445.am2014-2400","title":"Abstract 2400: Dinaciclib, an inhibitor of cyclin-dependent kinases (CDKs), impairs homologous recombination, abrogates G2 checkpoint arrest and sensitizes myeloma cells to PARP inhibition","display_name":"Abstract 2400: Dinaciclib, an inhibitor of cyclin-dependent kinases (CDKs), impairs homologous recombination, abrogates G2 checkpoint arrest and sensitizes myeloma cells to PARP inhibition","publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W2065024741","doi":"https://doi.org/10.1158/1538-7445.am2014-2400","mag":"2065024741"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2014-2400","doi":"https://doi.org/10.1158/1538-7445.am2014-2400","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-2400","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050462901","display_name":"David A. Alagpulinsa","orcid":"https://orcid.org/0000-0002-8737-4907","observed_orcids":["https://orcid.org/0000-0002-8737-4907"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Alagpulinsa","raw_affiliation_strings":["University of Arkansas for Medical Sciences, Little Rock, AR","University of Arkansas for Medical Sciences, Little Rock, AR#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]},{"raw_affiliation_string":"University of Arkansas for Medical Sciences, Little Rock, AR#TAB#","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039870327","display_name":"Shmuel Yaccoby","orcid":"https://orcid.org/0000-0003-1823-3411","observed_orcids":["https://orcid.org/0000-0003-1823-3411"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shmuel Yaccoby","raw_affiliation_strings":["University of Arkansas for Medical Sciences, Little Rock, AR","University of Arkansas for Medical Sciences, Little Rock, AR#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]},{"raw_affiliation_string":"University of Arkansas for Medical Sciences, Little Rock, AR#TAB#","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039791222","display_name":"Srinivas Ayyadevara","orcid":"https://orcid.org/0000-0002-4572-6361","observed_orcids":["https://orcid.org/0000-0002-4572-6361"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srinivas Ayyadevara","raw_affiliation_strings":["University of Arkansas for Medical Sciences, Little Rock, AR","University of Arkansas for Medical Sciences, Little Rock, AR#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]},{"raw_affiliation_string":"University of Arkansas for Medical Sciences, Little Rock, AR#TAB#","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010384852","display_name":"Robert J. Shmookler Reis","orcid":"https://orcid.org/0000-0002-4691-0734","observed_orcids":["https://orcid.org/0000-0002-4691-0734"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. S. Reis","raw_affiliation_strings":["University of Arkansas for Medical Sciences, Little Rock, AR","University of Arkansas for Medical Sciences, Little Rock, AR#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]},{"raw_affiliation_string":"University of Arkansas for Medical Sciences, Little Rock, AR#TAB#","institution_ids":["https://openalex.org/I79620101"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I79620101"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"74","issue":"19_Supplement","first_page":"2400","last_page":"2400"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.6801999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.6801999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.18799999356269836,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.10130000114440918,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dinaciclib","display_name":"dinaciclib","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cyclin-dependent-kinases","display_name":"cyclin-dependent kinases","score":0.8420000076293945},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9419999718666077},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.9599999785423279},{"id":"https://openalex.org/keywords/parp-inhibition","display_name":"PARP inhibition","score":0.9340000152587891},{"id":"https://openalex.org/keywords/veliparib","display_name":"veliparib","score":0.9440000057220459},{"id":"https://openalex.org/keywords/brca1-phosphorylation","display_name":"BRCA1 phosphorylation","score":0.8080000281333923},{"id":"https://openalex.org/keywords/atm","display_name":"ATM","score":0.44600000977516174},{"id":"https://openalex.org/keywords/cdk5","display_name":"cyclin-dependent kinase 5","score":0.7210000157356262},{"id":"https://openalex.org/keywords/double-strand-break-repair","display_name":"DNA double-strand break repair","score":0.8619999885559082},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.6470000147819519},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.6499999761581421},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.4779999852180481},{"id":"https://openalex.org/keywords/drug-combination-therapy","display_name":"drug combination therapy","score":0.3880000114440918},{"id":"https://openalex.org/keywords/cdk9","display_name":"CDK9","score":0.3179999887943268}],"concepts":[{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.7493586540222168},{"id":"https://openalex.org/C2781312401","wikidata":"https://www.wikidata.org/wiki/Q7919041","display_name":"Veliparib","level":5,"score":0.6398621797561646},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.5858369469642639},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5494881272315979},{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.5410425066947937},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.5309578776359558},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.5094664692878723},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.49132290482521057},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.46585211157798767},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4653718173503876},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.4514648914337158},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.4286867082118988},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.28481432795524597},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2032896876335144},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.10553020238876343},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.10055467486381531},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07116028666496277}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2014-2400","doi":"https://doi.org/10.1158/1538-7445.am2014-2400","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-2400","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8100000023841858,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2979457340","https://openalex.org/W2213491014","https://openalex.org/W2940175156","https://openalex.org/W2053439280","https://openalex.org/W2056920544","https://openalex.org/W2075890414","https://openalex.org/W2561121817","https://openalex.org/W2742102900","https://openalex.org/W4386696858","https://openalex.org/W4389235012"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Multiple":[2],"myeloma":[3,163,235,405,451],"(MM)":[4],"is":[5,78,105,109],"the":[6,17,198,288,333,389,460,465],"second":[7],"most":[8],"common":[9],"hematologic":[10],"malignancy,":[11],"and":[12,32,43,55,60,73,85,90,117,137,154,162,179,182,243,255,342,374,387,403,410,449],"yet":[13],"remains":[14],"incurable":[15],"in":[16,58,100,120,194,233,277,287,308,325,394],"majority":[18],"of":[19,34,39,62,113,148,176,188,200,204,270,290,328,336,339,344,355,391,438,459,464],"patients.":[20,167],"We":[21,145,168,209,283],"previously":[22],"observed":[23,284],"dysfunctional":[24],"homologous":[25,443],"recombination":[26],"(HR)":[27],"to":[28,141,173,185,196,207,262,297,305,318,407,453],"mediate":[29],"genomic":[30],"instability":[31],"progression":[33],"MM.CDKs":[35],"are":[36,273],"key":[37],"components":[38],"HR":[40,74,104,131,205,353,400],"DNA":[41,97,401],"repair":[42,84,354,402],"have":[44],"been":[45],"targeted":[46],"by":[47],"therapeutic":[48],"drugs":[49],"for":[50,70,80,123,420,468],"MM.":[51,124,421],"CDK1":[52],"phosphorylates":[53,65],"BRCA1,":[54],"CDK5":[56],"(upregulated":[57],"MM":[59,139,159,166],"predictive":[61],"patient":[63],"survival)":[64],"ATM,":[66],"modifications":[67],"considered":[68],"essential":[69],"checkpoint":[71,135,265,447],"activation":[72],"repair.":[75],"Poly(ADP-ribose)polymerase":[76],"(PARP)":[77],"required":[79],"single-strand":[81],"break":[82],"(SSB)":[83],"when":[86],"inhibited,":[87],"SSBs":[88],"accumulate":[89],"degenerate":[91],"into":[92],"double-strand":[93],"breaks":[94],"(DSBs)":[95],"during":[96],"replication,":[98],"resulting":[99],"cell":[101,160,385],"death":[102],"if":[103],"deficient.":[106],"Dinaciclib":[107],"(DC)":[108],"a":[110,228,278],"potent":[111],"inhibitor":[112,437],"CDK1,":[114],"2,":[115],"5":[116],"9,":[118],"currently":[119,274],"clinical":[121],"trials":[122],"Here,":[125],"we":[126],"show":[127],"that":[128,350],"DC":[129,201,211,271,321,351,376,397],"disrupts":[130,352],"repair,":[132,216],"abrogates":[133,445],"G2":[134,264,446],"arrest,":[136],"sensitizes":[138,404,450],"cells":[140,164,291,309,341,346,393,406,452],"PARP":[142,408,454],"inhibition.":[143,455],"Methods:":[144],"investigated":[146],"effects":[147,199,212],"DC,":[149,316,365],"doxorubicin":[150],"(topoisomerase":[151],"II":[152],"inhibitor),":[153],"veliparib":[155,312,319,363,373],"(PARP":[156],"inhibitor)":[157],"on":[158,202,213,330],"lines":[161],"from":[165],"used":[169,261],"confocal":[170],"immunofluorescence":[171],"microscopy":[172],"assess":[174,197],"formation":[175],"\u03b3H2AX,":[177],"BRCA1":[178,294,329],"RAD51":[180,302],"foci,":[181],"western":[183],"blotting":[184],"measure":[186],"levels":[187],"phospho-BRCA1":[189],"(at":[190],"Ser1497,CDK1":[191],"phosphorylation":[192,327],"site)":[193],"order":[195],"recruitment":[203],"proteins":[206],"DSBs.":[208,356],"measured":[210],"HR-mediated":[214],"DSB":[215],"following":[217,359],"transient":[218],"infection":[219],"with":[220,251,292,311,362],"adenovirus":[221],"encoding":[222],"I-SceI,":[223],"which":[224],"forms":[225],"DSBs":[226],"within":[227],"DR-GFP":[229,334],"reporter":[230],"chromosomally":[231],"integrated":[232],"MM.1S":[234],"cells.":[236],"Cell":[237,357],"viability":[238,358],"was":[239,260],"determined":[240],"using":[241],"WST-1":[242],"colony-formation":[244],"assays.":[245],"Flow":[246],"cytometry":[247],"after":[248],"dual":[249],"staining":[250],"propidium":[252],"iodide":[253],"(PI)/RNaseA":[254],"anti-phospho-histone":[256],"H3":[257],"(Ser10)":[258],"antibody":[259],"determine":[263],"activation.":[266],"In":[267,332],"vivo":[268],"consequences":[269],"treatment":[272,377,418],"being":[275],"examined":[276],"myeloma-xenograft":[279],"mouse":[280],"model.":[281],"Results:":[282],"significant":[285],"decreases":[286],"percentage":[289],"\u22655":[293,301],"foci":[295,303],"(46.7%":[296],"5.7%,":[298],"p<0.001)":[299],"or":[300,366,381],"(26%":[304],"4%,":[306],"p<0.001),":[307],"treated":[310],"plus":[313],"20":[314],"nM":[315],"relative":[317],"alone.":[320],"elicited":[322],"\u223c8-fold":[323],"decrease":[324],"doxorubicin-induced":[326],"S1497.":[331],"assay":[335],"HR,":[337],"23.9%":[338],"vehicle-treated":[340],"4.2%":[343],"DC-treated":[345],"were":[347],"GFP+,":[348],"indicating":[349],"72h":[360],"treatments":[361],"\u00b1":[364],"vehicle":[367],"alone,":[368],"implied":[369],"synergistic":[370],"cytotoxicity":[371],"between":[372],"DC.":[375],"significantly":[378,398],"inhibited":[379],"doxorubicin-":[380],"veliparib-induced":[382],"G2/M":[383],"phase":[384],"accumulation":[386],"increased":[388],"fraction":[390],"mitotic":[392],"G2/M.":[395],"Conclusion:":[396],"impairs":[399,442],"inhibition,":[409],"this":[411],"combination":[412],"may":[413],"thus":[414],"offer":[415],"an":[416,436],"effective":[417],"strategy":[419],"Citation":[422],"Format:":[423],"David":[424],"A.":[425],"Alagpulinsa,":[426],"Shmuel":[427],"Yaccoby,":[428],"Srinivas":[429],"Ayyadevara,":[430],"Robert":[431],"J.":[432],"S.":[433],"Reis.":[434],"Dinaciclib,":[435],"cyclin-dependent":[439],"kinases":[440],"(CDKs),":[441],"recombination,":[444],"arrest":[448],"[abstract].":[456],"In:":[457],"Proceedings":[458],"105th":[461],"Annual":[462],"Meeting":[463],"American":[466],"Association":[467],"Cancer":[469,480],"Research;":[470],"2014":[471],"Apr":[472],"5-9;":[473],"San":[474],"Diego,":[475],"CA.":[476],"Philadelphia":[477],"(PA):":[478],"AACR;":[479],"Res":[481],"2014;74(19":[482],"Suppl):Abstract":[483],"nr":[484],"2400.":[485],"doi:10.1158/1538-7445.AM2014-2400":[486]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}